Marpai (MRAI) Competitors $0.96 -0.03 (-3.27%) As of 02/21/2025 10:17 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrends MRAI vs. ENZ, CCM, NIVF, KDLY, BRTX, MGRX, OPGN, SSY, DHAC, and VSEEShould you be buying Marpai stock or one of its competitors? The main competitors of Marpai include Enzo Biochem (ENZ), Concord Medical Services (CCM), NewGenIvf Group (NIVF), Kindly MD (KDLY), BioRestorative Therapies (BRTX), Mangoceuticals (MGRX), OpGen (OPGN), SunLink Health Systems (SSY), Digital Health Acquisition (DHAC), and Vsee Health (VSEE). These companies are all part of the "healthcare" industry. Marpai vs. Enzo Biochem Concord Medical Services NewGenIvf Group Kindly MD BioRestorative Therapies Mangoceuticals OpGen SunLink Health Systems Digital Health Acquisition Vsee Health Enzo Biochem (NYSE:ENZ) and Marpai (NASDAQ:MRAI) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, community ranking, institutional ownership and dividends. Which has more volatility & risk, ENZ or MRAI? Enzo Biochem has a beta of 0.81, suggesting that its stock price is 19% less volatile than the S&P 500. Comparatively, Marpai has a beta of 5.02, suggesting that its stock price is 402% more volatile than the S&P 500. Do insiders & institutionals believe in ENZ or MRAI? 36.9% of Enzo Biochem shares are owned by institutional investors. Comparatively, 49.8% of Marpai shares are owned by institutional investors. 11.4% of Enzo Biochem shares are owned by insiders. Comparatively, 61.3% of Marpai shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Do analysts prefer ENZ or MRAI? Marpai has a consensus target price of $6.00, indicating a potential upside of 526.57%. Given Marpai's stronger consensus rating and higher possible upside, analysts clearly believe Marpai is more favorable than Enzo Biochem.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Enzo Biochem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Marpai 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is ENZ or MRAI more profitable? Enzo Biochem has a net margin of -75.34% compared to Marpai's net margin of -85.70%. Marpai's return on equity of 0.00% beat Enzo Biochem's return on equity.Company Net Margins Return on Equity Return on Assets Enzo Biochem-75.34% -7.96% -5.49% Marpai -85.70%N/A -100.23% Does the MarketBeat Community favor ENZ or MRAI? Enzo Biochem received 210 more outperform votes than Marpai when rated by MarketBeat users. However, 66.67% of users gave Marpai an outperform vote while only 53.67% of users gave Enzo Biochem an outperform vote. CompanyUnderperformOutperformEnzo BiochemOutperform Votes21253.67% Underperform Votes18346.33% MarpaiOutperform Votes266.67% Underperform Votes133.33% Which has preferable valuation & earnings, ENZ or MRAI? Enzo Biochem has higher earnings, but lower revenue than Marpai. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnzo Biochem$31.91M0.84-$26.08MN/AN/AMarpai$37.15M0.37-$28.75M-$2.64-0.36 Does the media favor ENZ or MRAI? In the previous week, Enzo Biochem had 1 more articles in the media than Marpai. MarketBeat recorded 1 mentions for Enzo Biochem and 0 mentions for Marpai. Enzo Biochem's average media sentiment score of 0.46 beat Marpai's score of 0.00 indicating that Enzo Biochem is being referred to more favorably in the media. Company Overall Sentiment Enzo Biochem Neutral Marpai Neutral SummaryMarpai beats Enzo Biochem on 9 of the 16 factors compared between the two stocks. Get Marpai News Delivered to You Automatically Sign up to receive the latest news and ratings for MRAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MRAI vs. The Competition Export to ExcelMetricMarpaihealth & allied services, not elsewhere classified IndustryBusiness SectorNASDAQ ExchangeMarket Cap$13.87M$1.94B$7.80B$8.98BDividend YieldN/A7.61%2.20%3.85%P/E Ratio-0.3616.6833.8518.82Price / Sales0.377.0367.5776.45Price / CashN/A9.3032.3137.47Price / Book-0.564.545.424.64Net Income-$28.75M$87.49M$187.27M$245.69M7 Day Performance5.23%-2.91%-2.92%-2.63%1 Month Performance-2.29%-4.26%-2.68%-2.37%1 Year Performance-33.03%-24.91%18.85%13.65% Marpai Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRAIMarpaiN/A$0.96-3.3%$6.00+526.6%-33.0%$13.87M$37.15M-0.36150Gap DownENZEnzo Biochem1.5046 of 5 stars$0.54+5.9%N/A-61.2%$28.21M$31.91M0.00520Analyst ForecastNews CoverageCCMConcord Medical Services0.6104 of 5 stars$4.77-1.6%N/A-36.2%$20.70M$75.69M0.00970Analyst ForecastNews CoverageGap DownNIVFNewGenIvf Group2.2795 of 5 stars$1.95flatN/AN/A$19.79M$5.14M0.00N/ANews CoverageGap UpKDLYKindly MDN/A$2.89+15.6%N/AN/A$17.28MN/A0.00N/AHigh Trading VolumeBRTXBioRestorative Therapies3.1543 of 5 stars$2.29-6.9%$18.00+686.0%+32.0%$15.85M$150,000.00-1.507News CoverageMGRXMangoceuticals0.8031 of 5 stars$4.84+9.3%N/A-91.2%$12.04M$755,000.00-0.843News CoverageGap UpOPGNOpGenN/A$1.38+0.7%N/A-70.2%$11.54M$3.42M0.00100Analyst ForecastSSYSunLink Health SystemsN/A$0.96+13.2%N/A+18.5%$6.77M$32.44M-8.751,376Analyst ForecastGap UpHigh Trading VolumeDHACDigital Health AcquisitionN/A$1.87+7.5%N/A-84.6%$6.74MN/A0.002,021High Trading VolumeVSEEVsee HealthN/A$1.87+7.5%N/AN/A$6.73MN/A0.00N/AHigh Trading Volume Related Companies and Tools Related Companies Enzo Biochem Competitors Concord Medical Services Competitors NewGenIvf Group Competitors Kindly MD Competitors BioRestorative Therapies Competitors Mangoceuticals Competitors OpGen Competitors SunLink Health Systems Competitors Digital Health Acquisition Competitors Vsee Health Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MRAI) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marpai, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marpai With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
